Clinical Trial To Study The Anti-scarring Effect Of Cicatricell
Cicatricell
1 other identifier
interventional
52
1 country
1
Brief Summary
This study tries to prove that Cicatricell cream significantly reduces scarring with better wound appearance as compared to no treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 16, 2015
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedJune 5, 2024
June 1, 2024
3.8 years
September 16, 2015
June 4, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Improved wound appearance
improved wound appearance by surface area measurement
8 weeks to 6 months
improved wound appearance
wound indentation measurement with caliper
8 weeks to 6 months
improved wound appearance
wound bulge measured with caliper
8 weeks to 6 months
Modified Vancouver Scar Scale
a scale of visual assessment of a scar
8 weeks to 6 months
Manchester Scar Scale
A new quantitative scale for clinical scar assessment
8 weeks to 6 months
Study Arms (2)
treatment arm
EXPERIMENTALreceive cicatricell cream
control arm
NO INTERVENTIONto treatment
Interventions
Eligibility Criteria
You may qualify if:
- Signed IRB approved, written informed consent.
- Patient from 18 to 60 years of age.
- Patient who recently underwent a surgery involving linear surgical skin incisions of 5cm or more or patients with two exactly symmetrical separate incisions like bilateral inguinal hernia repair or bilateral mastectomy, CT surgery patients will be included.
You may not qualify if:
- Known skin allergies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UTMC
Toledo, Ohio, 43614, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2015
First Posted
January 13, 2017
Study Start
March 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2020
Last Updated
June 5, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share